# Reducing Dexamethasone Around Docetaxel Infusion

> **NCT02776436** · PHASE1 · COMPLETED · sponsor: **Leiden University Medical Center** · enrollment: 46 (actual)

## Conditions studied

- Breast Cancer
- Prostate Cancer

## Interventions

- **DRUG:** Dexamethasone
- **DRUG:** Prednisone

## Key facts

- **NCT ID:** NCT02776436
- **Lead sponsor:** Leiden University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2020-11-20
- **Final completion:** 2020-11-20
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02776436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02776436, "Reducing Dexamethasone Around Docetaxel Infusion". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT02776436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*